#366 The Rise of Computational Pathology: How AI is Shaping Cancer Diagnosis with Thomas Fuchs, CEO of Paige.AI

This week, James is joined by Dr Thomas Fuchs, Founder and Chief Scientist at Paige, a healthtech company using the power of AI to drive a new era of cancer discovery and treatment. Paige is the first company to receive FDA approval for a clinical AI application in digital pathology.It's cloud-based platform transforms pathologists’ workflow and increases diagnostic confidence as well as productivity on a global scale.Learn more: https://paige.ai/Apply to be a guest: www.thehealthtechpodcast.comSubscribe to Healthtech Pigeon 🐦:www.healthtechpigeon.comGet in touch with James: www.jamessomauroo.comLearn more about SomX for your healthtech company at somx.health